Piperidine derivative, process for producing the same, and use
    3.
    发明授权
    Piperidine derivative, process for producing the same, and use 失效
    哌啶衍生物,其制备方法和用途

    公开(公告)号:US07622487B2

    公开(公告)日:2009-11-24

    申请号:US10516252

    申请日:2003-05-29

    IPC分类号: A61K31/445 C07D403/12

    摘要: The present invention provides a compound represented by the formula: wherein Ar is an aryl group, an aralkyl group or an aromatic heterocyclic group, each of which may be substituted, R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an acyl group or an optionally substituted heterocyclic group, X is an oxygen atom or an optionally substituted imino group, Z is an optionally substituted methylene group, Ring A is an optionally further substituted piperidine ring, and Ring B is an optionally substituted aromatic ring, provided that when Z is a methylene group substituted with an oxo group, R1 is not a methyl group, and when Z is a methylene group substituted with a methyl group, Ring B is a substituted aromatic ring, or a salt thereof, which is a novel piperidine derivative having excellent antagonistic action for a tachykinin receptor and useful as a medicament, particularly an agent for preventing and/or treating urinary frequency and/or urinary incontinence.

    摘要翻译: 本发明提供由下式表示的化合物:其中Ar是芳基,芳烷基或芳族杂环基,其各自可以被取代,R 1是氢原子,任选取代的烃基,酰基或 任选取代的杂环基,X是氧原子或任选取代的亚氨基,Z是任选取代的亚甲基,环A是任选进一步取代的哌啶环,环B是任选取代的芳环,条件是当Z 是被氧基取代的亚甲基,R1不是甲基,当Z是被甲基取代的亚甲基时,环B是取代的芳香环或其盐,它是具有 用于速激肽受体的优异拮抗作用,可用作药物,特别是用于预防和/或治疗尿频和/或尿失禁的药剂。

    Piperidine derivative, process for producing the same, and use
    7.
    发明申请
    Piperidine derivative, process for producing the same, and use 失效
    哌啶衍生物,其制备方法和用途

    公开(公告)号:US20060167052A1

    公开(公告)日:2006-07-27

    申请号:US10516252

    申请日:2003-05-29

    IPC分类号: A61K31/454 C07D403/02

    摘要: The present invention provides a compound represented by the formula: wherein Ar is an aryl group, an aralkyl group or an aromatic heterocyclic group, each of which may be substituted, R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an acyl group or an optionally substituted heterocyclic group, X is an oxygen atom or an optionally lo substituted imino group, Z is an optionally substituted methylene group, Ring A is an optionally further substituted piperidine ring, and Ring B is an optionally substituted aromatic ring, provided that when Z is a methylene group substituted with an oxo group, R1 is not a methyl group, and 15 when Z is a methylene group substituted with a methyl group, Ring B is a substituted aromatic ring, or a salt thereof, which is a novel piperidine derivative having excellent antagonistic action for a tachykinin receptor and useful as a medicament, particularly an agent for preventing and/or treating urinary frequency and/or urinary incontinence.

    摘要翻译: 本发明提供由下式表示的化合物:其中Ar是芳基,芳烷基或芳族杂环基,其各自可以被取代,R 1是氢原子,任选地 取代烃基,酰基或任选取代的杂环基,X是氧原子或任选取代的亚氨基,Z是任选取代的亚甲基,环A是任选进一步取代的哌啶环,环B是 任选取代的芳环,条件是当Z是被氧代基取代的亚甲基时,R 1不是甲基,而当Z是被甲基取代的亚甲基时,R 1是环B 是取代的芳香环或其盐,其是对速激肽受体具有优异拮抗作用的新型哌啶衍生物,并且可用作药物,特别是用于预防和/或治疗尿频和/或 尿失禁